# Vici Properties Inc.: financial statements, quarterly

VICI · NYSE · CIK 1705696 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vici.md) · [Financials](/companies/vici/financials.md) · [Filings](/companies/vici/filings.md) · [Insiders](/companies/vici/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/vici/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [904](/filings/0001705696-24-000119.md) | [932 d](/filings/0001705696-26-000034.md) | [951](/filings/0001705696-25-000087.md) | [957](/filings/0001705696-25-000107.md) | [965](/filings/0001705696-25-000132.md) | [976 d](/filings/0001705696-26-000034.md) | [984](/filings/0001705696-26-000069.md) | [1,001](/filings/0001705696-26-000090.md) | [1,007](/filings/0001705696-25-000132.md) | [1,013 d](/filings/0001705696-26-000034.md) | [1,019](/filings/0001705696-26-000069.md) | [1,059](/filings/0001705696-26-000090.md) |
| Cost of revenue | $m | [6.3](/filings/0001705696-24-000119.md) | [8.2 d](/filings/0001705696-26-000034.md) | [6.5](/filings/0001705696-25-000087.md) | [6.8](/filings/0001705696-25-000107.md) | [6.8](/filings/0001705696-25-000132.md) | [6.7 d](/filings/0001705696-26-000034.md) | [6.4](/filings/0001705696-26-000069.md) | [6.6](/filings/0001705696-26-000090.md) | [6.8](/filings/0001705696-25-000132.md) | [7.0 d](/filings/0001705696-26-000034.md) | [6.5](/filings/0001705696-26-000069.md) | [7.4](/filings/0001705696-26-000090.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [205](/filings/0001705696-23-000113.md) | [205 d](/filings/0001705696-24-000033.md) | [205](/filings/0001705696-24-000080.md) | [206](/filings/0001705696-25-000107.md) | [207](/filings/0001705696-25-000132.md) | [208 d](/filings/0001705696-26-000034.md) | [209](/filings/0001705696-26-000069.md) | [214](/filings/0001705696-26-000090.md) | [210](/filings/0001705696-25-000132.md) | [210 d](/filings/0001705696-26-000034.md) | [209](/filings/0001705696-26-000069.md) | [210](/filings/0001705696-26-000090.md) |
| Income tax | $m | [0.6](/filings/0001705696-24-000119.md) | [(9.8) d](/filings/0001705696-26-000034.md) | [1.6](/filings/0001705696-25-000087.md) | [3.2](/filings/0001705696-25-000107.md) | [2.5](/filings/0001705696-25-000132.md) | [2.4 d](/filings/0001705696-26-000034.md) | [(2.5)](/filings/0001705696-26-000069.md) | [5.6](/filings/0001705696-26-000090.md) | [3.9](/filings/0001705696-25-000132.md) | [(4.6) d](/filings/0001705696-26-000034.md) | [4.0](/filings/0001705696-26-000069.md) | [(0.5)](/filings/0001705696-26-000090.md) |
| Net income | $m | [556](/filings/0001705696-24-000119.md) | [748 d](/filings/0001705696-26-000034.md) | [590](/filings/0001705696-25-000087.md) | [741](/filings/0001705696-25-000107.md) | [733](/filings/0001705696-25-000132.md) | [615 d](/filings/0001705696-26-000034.md) | [544](/filings/0001705696-26-000069.md) | [865](/filings/0001705696-26-000090.md) | [762](/filings/0001705696-25-000132.md) | [605 d](/filings/0001705696-26-000034.md) | [872](/filings/0001705696-26-000069.md) | [527](/filings/0001705696-26-000090.md) |
| Diluted EPS | $ per share | [0.55](/filings/0001705696-24-000119.md) | not reported | [0.57](/filings/0001705696-25-000087.md) | [0.71](/filings/0001705696-25-000107.md) | [0.70](/filings/0001705696-25-000132.md) | not reported | [0.51](/filings/0001705696-26-000069.md) | [0.82](/filings/0001705696-26-000090.md) | [0.71](/filings/0001705696-25-000132.md) | not reported | [0.82](/filings/0001705696-26-000069.md) | [0.48](/filings/0001705696-26-000090.md) |
| Basic EPS | $ per share | [0.55](/filings/0001705696-24-000119.md) | not reported | [0.57](/filings/0001705696-25-000087.md) | [0.71](/filings/0001705696-25-000107.md) | [0.70](/filings/0001705696-25-000132.md) | not reported | [0.51](/filings/0001705696-26-000069.md) | [0.82](/filings/0001705696-26-000090.md) | [0.71](/filings/0001705696-25-000132.md) | not reported | [0.82](/filings/0001705696-26-000069.md) | [0.48](/filings/0001705696-26-000090.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.5](/filings/0001705696-23-000113.md) | [0.5](/filings/0001705696-25-000033.md) | [0.5](/filings/0001705696-24-000080.md) | [0.3](/filings/0001705696-24-000099.md) | [0.4](/filings/0001705696-24-000119.md) | [0.5](/filings/0001705696-26-000034.md) | [0.3](/filings/0001705696-25-000087.md) | [0.2](/filings/0001705696-25-000107.md) | [0.5](/filings/0001705696-25-000132.md) | [0.6](/filings/0001705696-26-000090.md) | [0.5](/filings/0001705696-26-000069.md) | [0.3](/filings/0001705696-26-000090.md) |
| Total assets | $bn | [42.8](/filings/0001705696-23-000113.md) | [44.1](/filings/0001705696-25-000033.md) | [44.2](/filings/0001705696-24-000080.md) | [44.5](/filings/0001705696-24-000099.md) | [44.9](/filings/0001705696-24-000119.md) | [45.4](/filings/0001705696-26-000034.md) | [45.5](/filings/0001705696-25-000087.md) | [46.1](/filings/0001705696-25-000107.md) | [46.5](/filings/0001705696-25-000132.md) | [46.7](/filings/0001705696-26-000090.md) | [47.1](/filings/0001705696-26-000069.md) | [48.3](/filings/0001705696-26-000090.md) |
| Total liabilities | $bn | [18.3](/filings/0001705696-23-000113.md) | [18.4](/filings/0001705696-25-000033.md) | [18.3](/filings/0001705696-24-000080.md) | [18.4](/filings/0001705696-24-000099.md) | [18.4](/filings/0001705696-24-000119.md) | [18.4](/filings/0001705696-26-000034.md) | [18.5](/filings/0001705696-25-000087.md) | [18.6](/filings/0001705696-25-000107.md) | [18.4](/filings/0001705696-25-000132.md) | [18.5](/filings/0001705696-26-000090.md) | [18.5](/filings/0001705696-26-000069.md) | [18.7](/filings/0001705696-26-000090.md) |
| Long-term debt | $bn | [16.7](/filings/0001705696-23-000113.md) | [16.7](/filings/0001705696-25-000033.md) | [16.7](/filings/0001705696-24-000080.md) | [16.7](/filings/0001705696-24-000099.md) | [16.7](/filings/0001705696-24-000119.md) | [16.7](/filings/0001705696-26-000034.md) | [16.8](/filings/0001705696-25-000087.md) | [16.9](/filings/0001705696-25-000107.md) | [16.8](/filings/0001705696-25-000132.md) | [16.8](/filings/0001705696-26-000090.md) | [16.8](/filings/0001705696-26-000069.md) | [16.9](/filings/0001705696-26-000090.md) |
| Shareholders' equity | $bn | [24.2](/filings/0001705696-23-000113.md) | [25.3](/filings/0001705696-25-000033.md) | [25.4](/filings/0001705696-24-000080.md) | [25.7](/filings/0001705696-24-000099.md) | [26.1](/filings/0001705696-24-000119.md) | [26.5](/filings/0001705696-26-000034.md) | [26.6](/filings/0001705696-25-000087.md) | [27.0](/filings/0001705696-25-000107.md) | [27.7](/filings/0001705696-25-000132.md) | [27.8](/filings/0001705696-26-000090.md) | [28.2](/filings/0001705696-26-000069.md) | [29.2](/filings/0001705696-26-000090.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [552 d](/filings/0001705696-24-000119.md) | [576 d](/filings/0001705696-26-000034.md) | [544](/filings/0001705696-25-000087.md) | [615 d](/filings/0001705696-25-000107.md) | [579 d](/filings/0001705696-25-000132.md) | [644 d](/filings/0001705696-26-000034.md) | [592](/filings/0001705696-26-000069.md) | [640 d](/filings/0001705696-26-000090.md) | [586 d](/filings/0001705696-25-000132.md) | [692 d](/filings/0001705696-26-000034.md) | [632](/filings/0001705696-26-000069.md) | [728 d](/filings/0001705696-26-000090.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [383 d](/filings/0001705696-24-000119.md) | [422 d](/filings/0001705696-26-000034.md) | [435](/filings/0001705696-25-000087.md) | [433 d](/filings/0001705696-25-000107.md) | [433 d](/filings/0001705696-25-000132.md) | [453 d](/filings/0001705696-26-000034.md) | [459](/filings/0001705696-26-000069.md) | [457 d](/filings/0001705696-26-000090.md) | [457 d](/filings/0001705696-25-000132.md) | [481 d](/filings/0001705696-26-000034.md) | [481](/filings/0001705696-26-000069.md) | [481 d](/filings/0001705696-26-000090.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [964](/filings/0001705696-23-000113.md) | [1,004](/filings/0001705696-24-000080.md) | [1,008](/filings/0001705696-24-000099.md) | [1,014](/filings/0001705696-24-000119.md) | [1,043](/filings/0001705696-25-000087.md) | [1,043](/filings/0001705696-25-000107.md) | [1,048](/filings/0001705696-25-000132.md) | [1,056](/filings/0001705696-26-000069.md) | [1,057](/filings/0001705696-26-000090.md) | [1,068](/filings/0001705696-25-000132.md) | [1,069](/filings/0001705696-26-000069.md) | [1,090](/filings/0001705696-26-000090.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,101,077,562 at 2026-07-28, from the cover of the [10-Q filed 2026-07-29](/filings/0001705696-26-000090.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.